TelesisBio_Logo_RGB.png
Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNA
November 03, 2023 12:00 ET | Telesis Bio
SAN DIEGO, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the commercial release of its BioXp®...
GMILogo_Vertical-Gradient.png
Cloning and Mutagenesis Market to hit USD 14.6 billion by 2032, says Global Market Insights Inc.
August 07, 2023 22:30 ET | Global Market Insights Inc.
Selbyville, Delaware, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Cloning And Mutagenesis Market size is expected to be worth USD 14.6 billion by 2032. The industry expansion is backed by a wide range of...
TelesisBio_Logo_RGB.png
Telesis Bio Announces First Commercial Shipment of BioXp® Select DNA Cloning Kit
May 22, 2023 12:00 ET | Telesis Bio
SAN DIEGO, May 22, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the first commercial shipment of its...
logo_Codex_landscape_color_RGB (1).png
Codex DNA Announces Plan to Change Corporate Name to Telesis Bio
October 12, 2022 09:00 ET | Codex DNA, Inc.
SAN DIEGO, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a leader in automated multi-omic and synthetic biology solutions, today announced a plan to change its Company name to...
logo_Codex_landscape_color_RGB (1).png
Codex DNA weitet Anwendung der firmeneigenen Fehlerkorrekturtechnologie aus
October 04, 2022 09:00 ET | Codex DNA, Inc.
SAN DIEGO, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (NASDAQ: DNAY), ein Pionier im Bereich automatisierter Tischsysteme für die synthetische Biologie, gab heute die Markteinführung der...
logo_Codex_landscape_color_RGB (1).png
Codex DNA étend l'application de la technologie exclusive de correction des erreurs
October 04, 2022 09:00 ET | Codex DNA, Inc.
SAN DIEGO, 04 oct. 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (NASDAQ : DNAY), un pionnier des systèmes de paillasse automatisés de biologie synthétique, a annoncé aujourd'hui le lancement commercial...
logo_Codex_landscape_color_RGB (1).png
Codex DNA Expands Application of Proprietary Error Correction Technology
October 04, 2022 09:00 ET | Codex DNA, Inc.
SAN DIEGO, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (NASDAQ: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced commercial release of BioXp® Error-corrected...
logo_Codex_landscape_color_RGB (1).png
Codex DNA Showcases Next Generation Automated Synthetic Biology Workstation at World of Technology & Science in Utrecht, Netherlands
September 26, 2022 07:00 ET | Codex DNA, Inc.
SAN DIEGO, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (NASDAQ: DNAY), a pioneer in automated benchtop synthetic biology systems, will showcase its recently released BioXp™ 9600 system at the...
logo_Codex_landscape_color_RGB (1).png
Codex DNA Debuts Next-Generation Automated Synthetic Biology Workstation
September 19, 2022 07:00 ET | Codex DNA, Inc.
SAN DIEGO, Sept. 19, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (NASDAQ: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced commercial release and first shipment of the...